BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 30909187)

  • 1. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of low miR-144 expression in gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 20(4):547-552. PubMed ID: 28800316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
    Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
    Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer.
    Feng R; Beeharry MK; Lu S; Sah BK; Yuan F; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 22(1):119-126. PubMed ID: 29562500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
    Hou CG; Luo XY; Li G
    Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
    Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of microRNA-195 in the serum of patients with gastric cancer and its relationship with the clinicopathological staging of the cancer.
    Shen YH; Xie ZB; Yue AM; Wei QD; Zhao HF; Yin HD; Mai W; Zhong XG; Huang SR
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1283-7. PubMed ID: 27097947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
    Ren C; Chen H; Han C; Fu D; Wang D; Shen M
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.
    Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H
    Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum miR-25 in non-small-cell lung cancer.
    Li J; Yu M; Liu Z; Liu B
    Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Serum Exosomal microRNA-134 Expression and Its Prognostic Value in Gastric Cancer.
    Jin Z; Song Y; Lian C; Gao L
    Ann Clin Lab Sci; 2022 Jul; 52(4):563-570. PubMed ID: 36197781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.